trending Market Intelligence /marketintelligence/en/news-insights/trending/ogwpnhi5a6gtfrk4quejja2 content esgSubNav
In This List

Novan board member steps down

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Novan board member steps down

Novan Inc. said Sean Murphy stepped down as a class III director on Sept. 5.

His resignation was due to personal reasons and not the result of a disagreement with the company, Novan said in an SEC filing.

Morrisville, N.C.-based Novan develops and sells nitric oxide-based therapies to treat skin diseases and and illnesses mediated by cancer-causing viruses.